Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 12;14(12):2766.
doi: 10.3390/v14122766.

The Origin of Capsid-Derived Immune Complexes and Their Impact on HBV-Induced Liver Diseases

Xiaonan Zhang  1   2 , Yijie Tang  2 , Min Wu  2 , Cong Wang  2 , Lyuyin Hu  1 , Zhanqing Zhang  2
Affiliations

The Origin of Capsid-Derived Immune Complexes and Their Impact on HBV-Induced Liver Diseases

Xiaonan Zhang et al. Viruses. .

Abstract

Over 240 million people worldwide are chronically infected with Hepatitis B Virus (HBV), a hepatotropic DNA virus with an evolutionary root of over 400 million years. Persistent HBV infection exhibits distinct and diverse phases of disease, from minimal liver pathology to fulminant Hepatitis, that vary in duration and severity among individuals. Although huge progress has been made in HBV research which has yielded an effective prophylactic vaccine and potent antiviral therapy, our understanding of its virology and immunobiology is still far from complete. For example, the recent re-discovery of serum HBV RNA in chronic Hepatitis B (CHB) patients has led to the proposal of noncanonical viral particles such as RNA virion and capsid-derived immune complex (Capsid-Antibody-Complexes, CACs) that contradict long-established basic theory. Furthermore, the existence of capsid-derived immune complex may hint at novel mechanism of HBV-induced liver disease. Here, we summarize the past and recent literature on HBV-induced immune complex. We propose that the release of capsid-derived particles by HBV has its deep evolutionary origin, and the associated complement activation serves as an indispensable trigger for intrahepatic damage and a catalyst for further cell-mediated immunopathology.

Keywords: HBV; capsid-antibody-complexes; chronic hepatitis B; liver fibrosis; liver inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Proposed mechanism of CACs mediated liver injury. ADCC: antibody-dependent cellular cytotoxicity; MAC: membrane attack complex; APC: antigen presenting cell.
See this image and copyright information in PMC

References

    1. Sarin S., Kumar M., Lau G., Abbas Z., Chan H., Chen C., Chen D., Chen H., Chen P., Chien R. Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update. Hepatol. Int. 2016;10:1–98. - PMC - PubMed
    1. Ott J.J., Stevens G.A., Groeger J., Wiersma S.T. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–2219. doi: 10.1016/j.vaccine.2011.12.116. - DOI - PubMed
    1. Nayagam S., Thursz M., Sicuri E., Conteh L., Wiktor S., Low-Beer D., Hallett T.B. Requirements for global elimination of hepatitis B: A modelling study. Lancet Infect. Dis. 2016;16:1399–1408. doi: 10.1016/S1473-3099(16)30204-3. - DOI - PubMed
    1. Ott J.J., Horn J., Krause G., Mikolajczyk R.T. Time trends of chronic HBV infection over prior decades—A global analysis. J. Hepatol. 2017;66:48–54. doi: 10.1016/j.jhep.2016.08.013. - DOI - PubMed
    1. Zhang X., Wang X., Wu M., Ghildyal R., Yuan Z. Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future. Front. Microbiol. 2021;12:715450. doi: 10.3389/fmicb.2021.715450. - DOI - PMC - PubMed

Publication types

LinkOut - more resources